INMUNE BIO INC. Accumulated Other Comprehensive Income
INMUNE BIO INC. (INMB) had Accumulated Other Comprehensive Income of -$823.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$823.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$727.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$737.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$764.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$823.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$727.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | -$737.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$764.00K 10-Q · filed 2025-10-30 | |
| 2025-06-30 | -$763.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$610.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$575.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | -$1.04M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | -$713.00K 10-Q · filed 2024-08-01 | |
| 2024-03-31 | -$669.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$799.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$735.00K 10-Q · filed 2023-11-01 | |
| 2023-06-30 | -$712.00K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | -$708.00K 10-Q · filed 2023-05-03 | |
| 2022-12-31 | -$699.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$1.14M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | -$701.00K 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $56.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.00K 10-K · filed 2023-03-02 | |
| 2021-09-30 | -$118.00K 10-Q · filed 2021-11-03 | |
| 2021-06-30 | -$50.00K 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $12.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $11.00K 10-K · filed 2022-03-03 | $10.71K 10-K · filed 2021-03-04 |
| 2020-09-30 | -$37.73K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $10.13K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | -$29.25K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | -$8.52K 10-K · filed 2021-03-04 | |
| 2019-09-30 | -$54.75K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | -$19.21K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $5.81K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $6.53K 10-K · filed 2020-03-11 | |
| 2017-12-31 | $32.04K 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |